Gösterilen 1 - 20 sonuçlar arası kayıtlar. 29 sonuç. Aranan kelime 'Vamsidhar Velcheti', Sorgu süresi: 0.09s Sonuçları Daraltın
  1. 1
    Role of immune-checkpoint inhibitors in lung cancer

    Role of immune-checkpoint inhibitors in lung cancer Yazar: Prantesh Jain, Chhavi Jain, Vamsidhar Velcheti

    Baskı/Yayın Bilgisi 2018-01-01
    Tam Metin Erişim
    Makale
  2. 2
    Real-world outcomes of first-line pembrolizumab plus pemetrexed-carboplatin for metastatic nonsquamous NSCLC at US oncology practices

    Real-world outcomes of first-line pembrolizumab plus pemetrexed-carboplatin for metastatic nonsquamous NSCLC at US oncology practices Yazar: Vamsidhar Velcheti, Xiaohan Hu, Bilal Piperdi, Thomas Burke

    Baskı/Yayın Bilgisi 2021-04-01
    Tam Metin Erişim
    Makale
  3. 3
    Long-Term Real-World Outcomes of First-Line Pembrolizumab Monotherapy for Metastatic Non-Small Cell Lung Cancer With ≥50% Expression of Programmed Cell Death-Ligand 1

    Long-Term Real-World Outcomes of First-Line Pembrolizumab Monotherapy for Metastatic Non-Small Cell Lung Cancer With ≥50% Expression of Programmed Cell Death-Ligand 1 Yazar: Vamsidhar Velcheti, Xiaohan Hu, Lingfeng Yang, M. Catherine Pietanza, Thomas Burke

    Baskı/Yayın Bilgisi 2022-03-01
    Tam Metin Erişim
    Makale
  4. 4
    Pembrolizumab-combination therapy for previously untreated metastatic nonsquamous NSCLC: Real-world outcomes at US oncology practices

    Pembrolizumab-combination therapy for previously untreated metastatic nonsquamous NSCLC: Real-world outcomes at US oncology practices Yazar: Stephen V. Liu, Xiaohan Hu, Yeran Li, Bin Zhao, Thomas Burke, Vamsidhar Velcheti

    Baskı/Yayın Bilgisi 2022-10-01
    Tam Metin Erişim
    Makale
  5. 5
    Immunotherapy in non-small cell lung cancer: Past, present, and future directions

    Immunotherapy in non-small cell lung cancer: Past, present, and future directions Yazar: Salman R. Punekar, Elaine Shum, Cassandra Mia Grello, Sally C. Lau, Vamsidhar Velcheti

    Baskı/Yayın Bilgisi 2022-08-01
    Tam Metin Erişim
    Makale
  6. 6
    Real-world PD-L1 testing and distribution of PD-L1 tumor expression by immunohistochemistry assay type among patients with metastatic non-small cell lung cancer in the United States.

    Real-world PD-L1 testing and distribution of PD-L1 tumor expression by immunohistochemistry assay type among patients with metastatic non-small cell lung cancer in the United State... Yazar: Vamsidhar Velcheti, Pallavi D Patwardhan, Frank Xiaoqing Liu, Xin Chen, Xiting Cao, Thomas Burke

    Baskı/Yayın Bilgisi 2018-01-01
    Tam Metin Erişim
    Makale
  7. 7
    Objective measurement and clinical significance of IDO1 protein in hormone receptor-positive breast cancer

    Objective measurement and clinical significance of IDO1 protein in hormone receptor-positive breast cancer Yazar: Daniel E. Carvajal-Hausdorf, Nikita Mani, Vamsidhar Velcheti, Kurt A. Schalper, David L. Rimm

    Baskı/Yayın Bilgisi 2017-10-01
    Tam Metin Erişim
    Makale
  8. 8
    37 Quantitative Lung Airway Morphology (QuaLM) features on chest CT scans are associated with response and overall survival in lung cancer patients treated with checkpoint inhibitors

    37 Quantitative Lung Airway Morphology (QuaLM) features on chest CT scans are associated with response and overall survival in lung cancer patients treated with checkpoint inhibito... Yazar: Amit Gupta, Pingfu Fu, Vamsidhar Velcheti, Kaustav Bera, Mehdi Alilou, Anant Madabhushi, Thomas Patton, Pradnya Patil, Nathan Pennell

    Baskı/Yayın Bilgisi 2021-11-01
    Makale
  9. 9
    Expression and clinical significance of PD-L1, B7-H3, B7-H4 and TILs in human small cell lung Cancer (SCLC)

    Expression and clinical significance of PD-L1, B7-H3, B7-H4 and TILs in human small cell lung Cancer (SCLC) Yazar: Daniel Carvajal-Hausdorf, Mehmet Altan, Vamsidhar Velcheti, Scott N. Gettinger, Roy S. Herbst, David L. Rimm, Kurt A. Schalper

    Baskı/Yayın Bilgisi 2019-03-01
    Tam Metin Erişim
    Makale
  10. 10
    Trends in Lung Cancer Incidence and Mortality (1990-2019) in the United States: A Comprehensive Analysis of Gender and State-Level Disparities

    Trends in Lung Cancer Incidence and Mortality (1990-2019) in the United States: A Comprehensive Analysis of Gender and State-Level Disparities Yazar: Chinmay T. Jani, Harpreet Singh, Nour Abdallah, Christian Mouchati, Shreya Arora, Samuel Kareff, Justin Salciccioli, Carey C. Thomson, Vamsidhar Velcheti

    Baskı/Yayın Bilgisi 2023-09-01
    Tam Metin Erişim
    Makale
  11. 11
    High SOX2 levels predict better outcome in non-small cell lung carcinomas.

    High SOX2 levels predict better outcome in non-small cell lung carcinomas. Yazar: Vamsidhar Velcheti, Kurt Schalper, Xiaopan Yao, Huan Cheng, Mehmet Kocoglu, Kavita Dhodapkar, Yanhong Deng, Scott Gettinger, David L Rimm

    Baskı/Yayın Bilgisi 2013-01-01
    Tam Metin Erişim
    Makale
  12. 12
    Novel, non-invasive imaging approach to identify patients with advanced non-small cell lung cancer at risk of hyperprogressive disease with immune checkpoint blockade

    Novel, non-invasive imaging approach to identify patients with advanced non-small cell lung cancer at risk of hyperprogressive disease with immune checkpoint blockade Yazar: Amit Gupta, Vamsidhar Velcheti, Pranjal Vaidya, Kaustav Bera, Pradnya D Patil, Prantesh Jain, Mehdi Alilou, Mohammadhadi Khorrami, Anant Madabhushi

    Baskı/Yayın Bilgisi 2020-10-01
    Tam Metin Erişim
    Makale
  13. 13
    740 Pattern of natural killer (NK) cell (CD16+CD56+) expansion correlates with response outcomes with nemvaleukin alfa treatment

    740 Pattern of natural killer (NK) cell (CD16+CD56+) expansion correlates with response outcomes with nemvaleukin alfa treatment Yazar: Omid Hamid, Vamsidhar Velcheti, David F McDermott, Marc S Ernstoff, John L Hays, Yangchun Du, Sonali Panchabhai, Sarah Donatelli, Daniel G Smith, Ulka N Vaishampayan

    Baskı/Yayın Bilgisi 2023-11-01
    Makale
  14. 14
    Quantitative vessel tortuosity: A potential CT imaging biomarker for distinguishing lung granulomas from adenocarcinomas

    Quantitative vessel tortuosity: A potential CT imaging biomarker for distinguishing lung granulomas from adenocarcinomas Yazar: Mehdi Alilou, Mahdi Orooji, Niha Beig, Prateek Prasanna, Prabhakar Rajiah, Christopher Donatelli, Vamsidhar Velcheti, Sagar Rakshit, Michael Yang, Frank Jacono, Robert Gilkeson, Philip Linden, Anant Madabhushi

    Baskı/Yayın Bilgisi 2018-10-01
    Tam Metin Erişim
    Makale
  15. 15
    A prognostic and predictive computational pathology image signature for added benefit of adjuvant chemotherapy in early stage non-small-cell lung cancer

    A prognostic and predictive computational pathology image signature for added benefit of adjuvant chemotherapy in early stage non-small-cell lung cancer Yazar: Xiangxue Wang, Kaustav Bera, Cristian Barrera, Yu Zhou, Cheng Lu, Pranjal Vaidya, Pingfu Fu, Michael Yang, Ralph Alexander Schmid, Sabina Berezowska, Humberto Choi, Vamsidhar Velcheti, Anant Madabhushi

    Baskı/Yayın Bilgisi 2021-07-01
    Tam Metin Erişim
    Makale
  16. 16
    Neuroendocrine lineage commitment of small cell lung cancers can be leveraged into p53-independent non-cytotoxic therapy

    Neuroendocrine lineage commitment of small cell lung cancers can be leveraged into p53-independent non-cytotoxic therapy Yazar: Sudipta Biswas, Kai Kang, Kwok Peng Ng, Tomas Radivoyevitch, Kurt Schalper, Hua Zhang, Daniel J. Lindner, Anish Thomas, David MacPherson, Brian Gastman, David S. Schrump, Kwok-Kin Wong, Vamsidhar Velcheti, Yogen Saunthararajah

    Baskı/Yayın Bilgisi 2023-08-01
    Tam Metin Erişim
    Makale
  17. 17
    347 Clinical outcomes of ovarian cancer patients treated with ALKS 4230, a novel engineered cytokine, in combination with pembrolizumab: ARTISTRY-1 trial

    347 Clinical outcomes of ovarian cancer patients treated with ALKS 4230, a novel engineered cytokine, in combination with pembrolizumab: ARTISTRY-1 trial Yazar: Lucy Gilbert, Jameel Muzaffar, David McDermott, Vamsidhar Velcheti, Anna Spreafico, Valentina Boni, Christopher Hoimes, Ira Winer, Seth Rosen, Quincy Chu, Olivier Dumas, Aman Chauhan, Arvind Chaudhry, Piotr Tomczak, Debora Bruno, Elizabeth Dorn, Jessicca Rege

    Baskı/Yayın Bilgisi 2020-11-01
    Makale
  18. 18
    Image analysis reveals molecularly distinct patterns of TILs in NSCLC associated with treatment outcome

    Image analysis reveals molecularly distinct patterns of TILs in NSCLC associated with treatment outcome Yazar: Ruiwen Ding, Prateek Prasanna, Germán Corredor, Cristian Barrera, Philipp Zens, Cheng Lu, Priya Velu, Patrick Leo, Niha Beig, Haojia Li, Paula Toro, Sabina Berezowska, Vipul Baxi, David Balli, Merzu Belete, David L. Rimm, Vamsidhar Velcheti, Kurt Schalper, Anant Madabhushi

    Baskı/Yayın Bilgisi 2022-06-01
    Tam Metin Erişim
    Makale
  19. 19
    Role of tumor infiltrating lymphocytes and spatial immune heterogeneity in sensitivity to PD-1 axis blockers in non-small cell lung cancer

    Role of tumor infiltrating lymphocytes and spatial immune heterogeneity in sensitivity to PD-1 axis blockers in non-small cell lung cancer Yazar: Roy S Herbst, Vamsidhar Velcheti, Mari Mino-Kenudson, Matthew D Hellmann, David L Rimm, Kurt A Schalper, Anant Madabhushi, Justin Gainor, Germán Corredor, Miguel Lopez de Rodas, Venkata Nagineni, Arvind Ravi, Ila J Datar, Cristian Barrera, Lindsey Behlman, Jonathan W Riess

    Baskı/Yayın Bilgisi 2022-06-01
    Tam Metin Erişim
    Makale
  20. 20
    Combined Radiomic and Visual Assessment for Improved Detection of Lung Adenocarcinoma Invasiveness on Computed Tomography Scans: A Multi-Institutional Study

    Combined Radiomic and Visual Assessment for Improved Detection of Lung Adenocarcinoma Invasiveness on Computed Tomography Scans: A Multi-Institutional Study Yazar: Pranjal Vaidya, Kaustav Bera, Kaustav Bera, Philip A. Linden, Amit Gupta, Amit Gupta, Prabhakar Shantha Rajiah, David R. Jones, Matthew Bott, Harvey Pass, Robert Gilkeson, Robert Gilkeson, Frank Jacono, Kevin Li-Chun Hsieh, Gong-Yau Lan, Vamsidhar Velcheti, Anant Madabhushi, Anant Madabhushi

    Baskı/Yayın Bilgisi 2022-05-01
    Tam Metin Erişim
    Makale

Arama Araçları: